El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc by (c) Khoei et al., 2020
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/173409

Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Background: Bilirubin, a byproduct of hemoglobin breakdown and purported anti-oxidant, is thought to be cancer preventive. We conducted complementary serological and Mendelian randomization (MR) analyses to investigate whether alterations in circulating levels of bilirubin are associated with risk of colorectal cancer (CRC). We decided a priori to perform analyses separately in men and women based on suggestive evidence that associations may differ by sex. Methods: In a case-control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC), pre-diagnostic unconjugated bilirubin (UCB, the main component of total bilirubin) concentrations were measured by high-performance liquid chromatography in plasma samples of 1386 CRC cases and their individually matched controls. Additionally, 115 single-nucleotide polymorphisms (SNPs) robustly associated (P < 5 x 10(-8)) with circulating total bilirubin were instrumented in a 2-sample MR to test for a potential causal effect of bilirubin on CRC risk in 52,775 CRC cases and 45,940 matched controls in the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), the Colon Cancer Family Registry (CCFR), and the Colorectal Transdisciplinary (CORECT) study. Results: The associations between circulating UCB levels and CRC risk differed by sex (P-heterogeneity = 0.008). Among men, higher levels of UCB were positively associated with CRC risk (odds ratio [OR] = 1.19, 95% confidence interval [CI] = 1.04-1.36; per 1-SD increment of log-UCB). In women, an inverse association was observed (OR = 0.86 (0.76-0.97)). In the MR analysis of the mainUGT1A1SNP (rs6431625), genetically predicted higher levels of total bilirubin were associated with a 7% increase in CRC risk in men (OR = 1.07 (1.02-1.12);P = 0.006; per 1-SD increment of total bilirubin), while there was no association in women (OR = 1.01 (0.96-1.06);P = 0.73). Raised bilirubin levels, predicted by instrumental variables excluding rs6431625, were suggestive of an inverse association with CRC in men, but not in women. These differences by sex did not reach formal statistical significance (P-heterogeneity >= 0.2). Conclusions Additional insight into the relationship between circulating bilirubin and CRC is needed in order to conclude on a potential causal role of bilirubin in CRC development.

Matèries (anglès)

Citació

Citació

KHOEI, Nazlisadat seyed, JENAB, Mazda, MURPHY, Neil, BANBURY, Barbara l., CARRERAS TORRES, Robert, VIALLON, Vivian, KÜHN, Tilman, BUENO DE MESQUITA, H. bas, ALEKSANDROVA, Krasimira, CROSS, Amanda j., WEIDERPASS, Elisabete, STEPIEN, Magdalena, BULMER, Andrew, TJØNNELAND, Anne, BOUTRON-RUAULT, Marie-christine, SEVERI, Gianluca, CARBONNEL, Franck, KATZKE, Verena, BOEING, Heiner, BERGMANN, Manuela m., TRICHOPOULOU, Antonia, KARAKATSANI, Anna, MARTIMIANAKI, Georgia, PALLI, Domenico, TAGLIABUE, Giovanna, PANICO, Salvatore, TUMINO, Rosario, SACERDOTE, Carlotta, SKEIE, Guri, MERINO, Susana, BONET BONET, Catalina, RODRÍGUEZ BARRANCO, Miguel, GIL, Leire, CHIRLAQUE, María dolores, ARDANAZ, Eva, MYTE, Robin, HULTDIN, Johan, PÉREZ CORNAGO, Aurora, AUNE, Dagfinn, TSILIDIS, Konstantinos k., ALBANES, Demetrius, BARON, John a., BERNDT, Sonja i., BÉZIEAU, Stéphane, BRENNER, Hermann, CAMPBELL, Peter t., CASEY, Graham, CHAN, Andrew t., CHANG CLAUDE, Jenny, CHANOCK, Stephen j., COTTERCHIO, Michelle, GALLINGER, Steven, GRUBER, Stephen b., HAILE, Robert w., HAMPE, Jochen, HOFFMEISTER, Michael, HOPPER, John l., HSU, Li, HUYGHE, Jeroen r., JENKINS, Mark a., JOSHI, Amit d., KAMPMAN, Ellen, LARSSON, Susanna c., MARCHAND, Loïc le, LI, Christopher i., LI, Li, LINDBLOM, Annika, LINDOR, Noralane m., MARTÍN SÁNCHEZ, Vicente, MORENO AGUADO, Víctor, NEWCOMB, Polly a., OFFIT, Kenneth, OGINO, Shuji, PARFREY, Patrick s., PHAROAH, Paul d. p., RENNERT, Gad, SAKODA, Lori c., SCHAFMAYER, Clemens, SCHMIT, Stephanie l., SCHOEN, Robert e., SLATTERY, Martha l., THIBODEAU, Stephen n., ULRICH, Cornelia m., VAN DUIJNHOVEN, Franzel j. b., WEIGL, Korbinian, WEINSTEIN, Stephanie j., WHITE, Emily, WOLK, Alicja, WOODS, Michael o., WU, Anna h., ZHANG, Xuehong, FERRARI, Pietro, ANTON, Gabriele, PETERS, Annette, PETERS, Ulrike, GUNTER, Marc j., WAGNER, Karl-heinz, FREISLING, Heinz. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses. _BMC Medicine_. 2020. Vol. 18. [consulta: 26 de desembre de 2025]. [Disponible a: https://hdl.handle.net/2445/173409]

Exportar metadades

JSON - METS

Compartir registre